INIFY Laboratories AB (OSL:INIFY)
Norway · Delayed Price · Currency is NOK 6.95
+0.85 (13.93%)
At close: Oct 13, 2026
INIFY Laboratories AB Market Cap
INIFY Laboratories AB has a market cap or net worth of 746.95 million as of October 13, 2026. It is the 28,054th most valuable company in the world and the 193rd biggest in Norway. Its market cap has increased by 69.05% in one year.
Market Cap
746.95M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#193 Norway
PE Ratio
n/a
ChartMarket Cap Chart
Since June 20, 2022, INIFY Laboratories AB's market cap has increased from 452.37M to 746.95M, an increase of 65.12%. That is a compound annual growth rate of 12.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 746.95M | 95.59% |
| Dec 30, 2025 | 381.89M | 1.25% |
| Dec 30, 2024 | 377.20M | -32.76% |
| Dec 29, 2023 | 560.94M | 72.20% |
| Dec 30, 2022 | 325.75M | -27.99% |
| Jun 20, 2022 | 452.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 5.21B |
| Circio Holding ASA | 3.00B |
| Nordhealth AS | 2.21B |
| Thor Medical ASA | 1.84B |
| Nykode Therapeutics AS | 1.05B |
| ArcticZymes Technologies ASA | 980.57M |
| Omda AS | 970.01M |
| Vistin Pharma ASA | 798.20M |